ATE299932T1 - Verfahren der zellkultivierung - Google Patents

Verfahren der zellkultivierung

Info

Publication number
ATE299932T1
ATE299932T1 AT00925602T AT00925602T ATE299932T1 AT E299932 T1 ATE299932 T1 AT E299932T1 AT 00925602 T AT00925602 T AT 00925602T AT 00925602 T AT00925602 T AT 00925602T AT E299932 T1 ATE299932 T1 AT E299932T1
Authority
AT
Austria
Prior art keywords
cell cultivation
cell
culturing
protein
transformed
Prior art date
Application number
AT00925602T
Other languages
English (en)
Inventor
Yasuko Ozaki
Yasuo Koishihara
Shin-Ichi Kaiho
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ATE299932T1 publication Critical patent/ATE299932T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT00925602T 1999-05-10 2000-05-10 Verfahren der zellkultivierung ATE299932T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP12861499 1999-05-10
PCT/JP2000/002997 WO2000068371A1 (fr) 1999-05-10 2000-05-10 Procede de culture cellulaire

Publications (1)

Publication Number Publication Date
ATE299932T1 true ATE299932T1 (de) 2005-08-15

Family

ID=14989150

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00925602T ATE299932T1 (de) 1999-05-10 2000-05-10 Verfahren der zellkultivierung

Country Status (13)

Country Link
US (1) US6900052B1 (de)
EP (1) EP1176194B1 (de)
JP (1) JP4721522B2 (de)
KR (1) KR20020013538A (de)
CN (1) CN1182244C (de)
AT (1) ATE299932T1 (de)
AU (1) AU778787B2 (de)
CA (1) CA2372585A1 (de)
DE (1) DE60021373T2 (de)
ES (1) ES2241599T3 (de)
HK (2) HK1045715B (de)
NO (1) NO20015494L (de)
WO (1) WO2000068371A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8669109B2 (en) 2003-08-19 2014-03-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Methods of producing proteins in Chinese hamster ovary (CHO) cells
EP1694828B1 (de) * 2003-12-19 2011-03-16 Wyeth LLC Serumfreies vero-zellbanken-herstellungsverfahren
AU2008284015B2 (en) 2007-08-03 2014-05-15 Musc Foundation For Research Development Human monoclonal antibodies and methods for producing the same
HUE045635T2 (hu) 2009-04-09 2020-01-28 Sartorius Stedim Cellca Gmbh Eljárás továbbfejlesztett egysejtes klónozásra
US10519478B2 (en) 2015-01-26 2019-12-31 Ube Industries, Ltd. Method of producing substance
CA3134705A1 (en) * 2019-04-02 2020-10-08 Chugai Seiyaku Kabushiki Kaisha Method of introducing target-specific foreign gene
CN112980909A (zh) * 2021-02-26 2021-06-18 通用生物系统（安徽）有限公司 一种杂交瘤细胞无血清培养制备抗体的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5530101A (en) * 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
GB8911356D0 (en) * 1989-05-17 1989-07-05 Torrance Lesley A composition and a process to increase the survival of hybridoma cells
JPH0346562A (ja) * 1989-07-14 1991-02-27 Matsushita Electric Ind Co Ltd 免疫方法および免疫測定方法
AU630497B2 (en) * 1989-09-05 1992-10-29 Immunex Corporation Tumor necrosis factor-alpha and -beta receptors
NL9101680A (nl) * 1991-10-04 1993-05-03 Tno Werkwijze voor het genetisch modificeren van beenmergcellen van primaten, alsmede daarbij bruikbare cellen die recombinante retrovirale vectoren produceren.
SK40599A3 (en) * 1996-09-26 2000-06-12 Chugai Pharmaceutical Co Ltd Antibody against human parathormone related peptides
UA76934C2 (en) 1996-10-04 2006-10-16 Chugai Pharmaceutical Co Ltd Reconstructed human anti-hm 1.24 antibody, coding dna, vector, host cell, method for production of reconstructed human antibody, pharmaceutical composition and drug for treating myeloma containing reconstructed human anti-hm 1.24 antibody
JP3587664B2 (ja) * 1996-10-04 2004-11-10 中外製薬株式会社 再構成ヒト抗ｈｍ１．２４抗体
DE19653358A1 (de) * 1996-12-20 1998-06-25 Boehringer Mannheim Gmbh Immunoassay zum Nachweis von MIA

Also Published As

Publication number Publication date
EP1176194B1 (de) 2005-07-20
CA2372585A1 (en) 2000-11-16
HK1045715B (zh) 2005-06-03
WO2000068371A1 (fr) 2000-11-16
CN1182244C (zh) 2004-12-29
EP1176194A1 (de) 2002-01-30
KR20020013538A (ko) 2002-02-20
DE60021373T2 (de) 2006-04-27
WO2000068371A8 (fr) 2001-04-26
US6900052B1 (en) 2005-05-31
AU4430500A (en) 2000-11-21
JP4721522B2 (ja) 2011-07-13
CN1350580A (zh) 2002-05-22
ES2241599T3 (es) 2005-11-01
NO20015494L (no) 2002-01-09
NO20015494D0 (no) 2001-11-09
HK1045715A1 (en) 2002-12-06
DE60021373D1 (de) 2005-08-25
EP1176194A4 (de) 2002-09-18
HK1042522A1 (en) 2002-08-16
AU778787B2 (en) 2004-12-23

Similar Documents

Publication Publication Date Title
DK1249281T3 (da) Selvrensende overflade med hydrofob overfladestruktur og fremgangsmåde til fremstilling af denne
CY1108329T1 (el) Κυτταρικη καλλιεργεια
DE59906513D1 (de) Verfahren zur vernetzung von hydrogelen mit bis- und poly-2-oxazolidinonen
BR9803807B1 (pt) processo para preparação de uma enzima heteróloga através do cultivo de uma célula eucariótica transformada.
DK0843961T3 (da) Kimærisk mus og fremgangsmåde til at producere samme
FI923874A0 (fi) Medel foer bildande av hepatocytsferoider och foerfarande foer bildande av sferoider genom odling av hepatocyter.
DE69030765D1 (de) Medien zur zellzucht und verfahren dazu
DE60138029D1 (de) Verfahren zur herstellung von biopterinen
ATE454442T1 (de) Kontinuierliche fermentation
DE69725329D1 (de) Richtungsweisende markierung mit hervortretenden erhebungen und verfahren zur herstellung
DK1085083T3 (da) Dyrkningsmedium for dyreceller og fremgangsmåde til proteinfremstilling under anvendelse af dette
ATE536372T1 (de) Verfahren zur hoher expression der aktiven form von lymphotoxin-beta-rezeptor-immunglobulin fusionsproteinen, und deren reinigung
ATE553210T1 (de) Verfahren zur herstellung von l-threonin unter verwendung eines mikroorganismus mit inaktivierten galr gen.
DE60307615D1 (de) Zellkulturmedium
DE60329640D1 (de) Verfahren zur Herstellung von N-Monoalkyl-Beta-Aminoalkoholen
ATE299932T1 (de) Verfahren der zellkultivierung
FI922409L (fi) Foerfarande foer cellodling.
DE60129547D1 (de) Verfahren zur kultivierung von mikroorganismen
ATE166392T1 (de) Verfahren zur modulierung der produktion von sekundären metaboliten
DK0756003T3 (da) Fremgangsmåde til dyrkning af dyreceller
DK1238057T3 (da) Fremgangsmåde til produktion af vedhæftende dyreceller
DE10158713A8 (de) Träger mit immobilisierten Antigenen oder Antikörpern und Verfahren zu dessen Herstellen
DE60126865D1 (de) Enzymatisches Verfahren zur Markierung von Proteinen mit Isotopen
ATE306521T1 (de) Polycarbonat-substrate
ATE288476T1 (de) Herstellung von proteinen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties